Results 61 to 70 of about 566 (120)

Predictive Value of Microfilariae-Based Stop-MDA Thresholds After Triple Drug Therapy With IDA Against Lymphatic Filariasis in Treatment-Naive Indian Settings. [PDF]

Clin Infect Dis
James A, Coffeng LE, Blok DJ, King JD, de Vlas SJ, Stolk WA.   +5 more
europepmc   +1 more source

Ongoing transmission of lymphatic filariasis in Samoa 4.5 years after one round of triple-drug mass drug administration. [PDF]

PLoS Negl Trop Dis
Mayfield HJ, Sartorius B, Sheridan S, Howlett M, Martin BM, Thomsen R, Tofaeono-Pifeleti R, Viali S, Graves PM, Lau CL.   +9 more
europepmc   +1 more source

A mixed-method study to improve outcome of mass drug administration in two TAS failed districts of Uttar Pradesh, India. [PDF]

PLoS Negl Trop Dis
Srivatsa A, Biswal P, Routray S, Prasad S, Bardosh K, Kumar P, Kumar A, Patnaik A, Anwar S, Singh VP.   +9 more
europepmc   +1 more source

First case of macrocyclic lactone-resistant Dirofilaria immitis in Europe - Cause for concern. [PDF]

Int J Parasitol Drugs Drug Resist
Traversa D, Diakou A, Colombo M, Kumar S, Long T, Chaintoutis SC, Venco L, Betti Miller G, Prichard R.   +8 more
europepmc   +1 more source

Shrinking the lymphatic filariasis map of Zimbabwe: Reassessing the population requiring treatment through confirmatory mapping.

Int J Infect Dis
Midzi N, Mutsaka-Makuvaza MJ, Phiri I, Palatio K, Bakajika D, Zouré HM, Juma E, Anderson M, Mwabvu R, Bockarie MJ, Cano J, Njenga SM.   +11 more
europepmc   +1 more source

Treatment of loiasis: a review of clinical management recommendations. [PDF]

Infect Dis Poverty
Ekoka Mbassi D, Dreeßen R, Zoleko Manego R, Davi SD, Nordmann T, Mischlinger J, Ramharter M.   +6 more
europepmc   +1 more source

Safety and effectiveness of triple-drug therapy with ivermectin, diethylcarbamazine, and albendazole in reducing lymphatic filariasis prevalence and clearing circulating filarial antigens in Mombasa, Kenya. [PDF]

Infect Dis Poverty
Khaemba C, Njenga SM, Omondi WP, Kirui E, Oluka M, Guantai A, Aklillu E.   +6 more
europepmc   +1 more source

Persons 'never treated' in mass drug administration for lymphatic filariasis: identifying programmatic and research needs from a series of research review meetings 2020-2021. [PDF]

Int Health
Brady MA, Toubali E, Baker M, Long E, Worrell C, Ramaiah K, Graves P, Hollingsworth TD, Kelly-Hope L, Stukel D, Tripathi B, Means AR, Matendechero SH, Krentel A.   +13 more
europepmc   +1 more source

The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation. [PDF]

PLoS Negl Trop Dis
Wood ND, Smith D, Kinrade SA, Sullivan MT, Rayner CR, Wesche D, Patel K, Rowland-Yeo K.   +7 more
europepmc   +1 more source

Global insights can accelerate India's journey towards the elimination of lymphatic filariasis as a public health problem. [PDF]

BMJ Glob Health
Jabir M, Rahi M.
europepmc   +1 more source